You are here

  • Roundtable Webcast: Emerging Anti-Angiogenesis Therapies in Pleural Mesothelioma

    In this roundtable discussion, three key opinion leaders exchange their views on the promise of emerging anti-angiogenics in malignant pleural mesothelioma (MPM). They will examine the latest clinical trial data and future directions in MPM treatment.

    Emerging Anti-Angiogenesis Therapies in Pleural Mesothelioma
  • Interactive Patient Case: Multidisciplinary Management of Malignant Pleural Mesothelioma

    How can the management of malignant pleural mesothelioma (MPM) be optimized? This interactive patient case will guide you through best practices in diagnosis and treatment, including options for resectable and unresectable disease.

    Interactive Patient Case: Multidisciplinary Management of Malignant Pleural Mesothelioma

Video

David J. Sugarbaker, MD
Baylor College of Medicine, Lung Institute, and Division of Thoracic Surgery
Baylor St. Luke's Medical Center
Houston, TX, USA

Share

Infographic

Understanding Malignant Pleural Mesothelioma

Jointly provided by the Elsevier Office of Continuing Medical Education and Excerpta Medica.